Adverse event reports from toll-free numbers considered "spontaneous" in PhRMA proposal.
This article was originally published in The Tan Sheet
Executive Summary
OTC SWITCH ADVERSE EVENT REPORTS FROM TOLL-FREE NUMBERS would be processed as spontaneous or unsolicited reports under a Pharmaceutical Research & Manufacturers of America proposed approach to adverse event reports from consumers that are medically unconfirmed. "Adverse experience reports that come to the attention of the marketing authorization holder through toll-free number(s) which appear as part of the approved labeling for an NDA prescription-to-OTC switch product should be handled as a spontaneous (unsolicited) report," PhRMA suggested.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning